These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 2517741)

  • 1. Bovine surfactant (surfactant TA) therapy in immature baboons with hyaline membrane disease.
    Vidyasagar D; Maeta H; Raju TN; John E; Bhat R; Go M; Dahiya U; Roberson Y; Yamin A; Narula A
    Pediatrics; 1985 Jun; 75(6):1132-42. PubMed ID: 3846883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized controlled trial of exogenous surfactant for the treatment of hyaline membrane disease.
    Gitlin JD; Soll RF; Parad RB; Horbar JD; Feldman HA; Lucey JF; Taeusch HW
    Pediatrics; 1987 Jan; 79(1):31-7. PubMed ID: 3540835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of patent ductus arteriosus after exogenous surfactant in baboons with hyaline membrane disease.
    Shimada S; Raju TN; Bhat R; Maeta H; Vidyasagar D
    Pediatr Res; 1989 Dec; 26(6):565-9. PubMed ID: 2602035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of severe hyaline membrane disease with a single-dose of natural exogenous surfactant of porcine origin. A randomized trial: immediate effects and outcome at 28 days of life].
    Walti H; Relier JP; Huon C; Monset-Couchard M; Scemama M; De Gamarra E; Moriette G; Curstedt T; Robertson B
    Arch Fr Pediatr; 1990 May; 47(5):329-34. PubMed ID: 2196030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [High frequency oscillation ventilation after surfactant use in hyaline membrane disease. Outcome of ventilation parameters].
    Claris O; Lapillonne A; Madinier-Chappat N; Miguet D; Salle BL
    Cah Anesthesiol; 1994; 42(3):325-8. PubMed ID: 7812856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of hyaline membrane disease by human amniotic fluid surfactant.
    Jin HZ; Chen C; Jin QL; Shao XM
    Chin Med J (Engl); 1989 Dec; 102(12):944-6. PubMed ID: 2517741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of hyaline membrane disease by administration of exogenous surfactant].
    Bonte F; Dehan M; de Fontanges A; Lindenbaum A; Perret L; Puisieux F
    Arch Fr Pediatr; 1985 May; 42(5):397-402. PubMed ID: 3907577
    [No Abstract]   [Full Text] [Related]  

  • 8. The prevention of hyaline membrane disease: new concepts and approaches to therapy.
    Farrell PM; Kotas RV
    Adv Pediatr; 1976; 23():213-69. PubMed ID: 795280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary surfactant replacement in respiratory distress syndrome.
    Vidyasagar D; Shimada S
    Clin Perinatol; 1987 Dec; 14(4):991-1015. PubMed ID: 3322633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Exogenous surfactants in neonatology].
    Zupan V; Meric M; Dehan M
    Rev Mal Respir; 1995; 12(6):642-5. PubMed ID: 8677364
    [No Abstract]   [Full Text] [Related]  

  • 11. Hyaline membrane disease.
    Farrell PM; Avery ME
    Am Rev Respir Dis; 1975 May; 111(5):657-88. PubMed ID: 1093459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neonatal respiratory distress syndrome and surfactant therapy; a brief review.
    Robertson B
    Eur Respir J Suppl; 1989 Mar; 3():73s-76s. PubMed ID: 2662999
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.